Viewing nowAtorvan Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 200700764 · Notified 2007.01.17 · Insurance code 648101430
Improvement of hyperlipidemia (including familial hyperlipidemia in children, etc.); prevention of cardiovascular disease (including myocardial infarction, etc.)
This medication helps reduce the risk of cardiovascular diseases. In particular, adults with multiple risk factors or patients with type 2 diabetes can lower their risk of cardiac-related problems such as myocardial infarction, stroke, and angina pectoris. It is also effective in reducing the risk of vascular interventions and hospitalizations for congestive heart failure. For patients with hyperlipidemia, it is used as an adjunct therapy to dietary interventions aimed at improving hypercholesterolemia and dyslipidemia levels. It also helps improve hypercholesterolemia in young pediatric patients, thereby reducing the risk of heart disease. This medication is used for reducing the risk of cardiovascular disease and improving hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring greater reductions in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45% or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol may be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
Ages 10 ~ 17: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may pose a risk of muscle problems, so any symptoms of muscle pain or weakness should be reported to a doctor immediately. Especially if there is a significant increase in muscle enzyme levels or if myopathy is suspected, the medication should be discontinued. Patients with allergies to this medication or those with severe liver function issues, pregnant or breastfeeding women, and children under the age of 10 should not take this medication. Caution should be exercised when using this medication in patients with liver disease or a history of alcohol abuse, the elderly, and those with decreased renal function. Since this medication can affect liver function, regular liver function tests should be conducted, and the medication should be discontinued immediately if symptoms of hepatitis or jaundice occur. Additionally, this medication may increase the risk of side effects when taken with certain other medications, so any other medications should be disclosed to a doctor or pharmacist. Women of childbearing age should use appropriate contraceptive methods while on this medication and discontinue use if pregnancy is confirmed. Breastfeeding women should not take this medication, and children or the elderly should have their doses adjusted under the guidance of a physician and should be closely monitored for side effects. In cases of overdose, there is no specific antidote, so treatment should be provided according to symptoms, and liver function and muscle enzyme levels should be monitored. The medication should be stored out of reach of children and kept in its original container to prevent degradation and misuse.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture ingress and should be stored at a safe temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.
White oval film-coated tablet
For domestic use: 30 tablets/bottle, 100 tablets/bottle, for export: 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.